Average bioequivalence study of clarithromycin tablets in healthy male volunteers

Journal of Clinical Pharmacy and Therapeutics

Volumn 28, Issue 3, 2003, Pages 187-190

  Lohitnavy, M ^a,c   Lohitnavy, O ^a   Sareekan, K ^a   Chaiyaput, W ^b  

^a NARESUAN UNIVERSITY   (Thailand)

^b Naresuan Military Hospital   (Thailand)

^c Department of Ecosystem Science and Sustainability   (United States)

Author keywords

Bioequivalence; Clarithromycin; Electrochemical detection; Pharmacokinetics

Indexed keywords

CLARITHROMYCIN; FASCAR;

ABDOMINAL DISCOMFORT; ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG TOLERABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; TABLET; THAILAND;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLARITHROMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MIDDLE AGED; TABLETS; THERAPEUTIC EQUIVALENCY;

EID: 0038480049     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2003.00479.x     Document Type: Article

References (9)

1. Langtry HD, Brogden RN (1997) Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients. Drugs, 53, 973-1004.
2. McCarty JM (2000) Clarithromycin in the management of community-acquired pneumonia. Clinical Therapeutics, 22, 281-294.
3. Alvarez-Elcoro S, Enzler MJ (1999) The macrolides: erythromycin, clarithromycin, and azithromycin. Mayo Clinic Proceeding, 74, 613-634.
4. Carbon C, Poole MD (1999) The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data. Journal of Chemotherapy, 11, 107-118.
5. Rodvold KA (1999) Clinical pharmacokinetics of clarithromycin. Clinical Pharmacokinetics, 37, 365-398.
6. Fraschini F, Scaglione F, Deinartini G (1993) Clarithromycin clinical pharmacokinetics. Clinical Pharmacokinetics, 25, 189-804.
7. Chu SY, Wilson DS, Deaton RL et al. (1993) Single- and multiple-dose pharmacokinetics of clarithromycin, a new macrolide antimicrobial. Journal of Clinical Pharmacology, 33, 719-726.
8. Chu SY, Sennello LT, Sonders RC (1991) Simultaneous determination of clarithromycin and (14R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection. Journal of Chromatography, 571, 199-208.
9. FDA (1992) FDA Guidelines. Rockville, MD: Bioequivalence Food and Drug Administration, Division of Bioequivalence, Office of Generic Drugs 1 July.